Quantum Natural Family Planning Pilot — QNFP  

Fertility Disorders Clinical Trial

Official title: Comparison of Two Hormonal Fertility Monitors for Use in Natural Family Planning

Status Completed

Clinical Trial Summary

•The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices to monitor the menstrual cycle.

Clinical Trial Description

• The Mira fertility monitoring system (www.miracare.com) is a new home-use hormone tracking device with the ability to quantitatively measure reproductive hormones in the urine but is also synced to a smart phone App that provides a graphic representation of the hormonal levels throughout a menstrual cycle.

• The Mira monitor will be compared to the ClearBlue Fertility Monitor for its ease of use, satisfaction, and accuracy.

• The Mira hormonal monitor and App system has not been tested for its use in Natural Family Planning (NFP).

• The Pilot study will involve current Marquette Method users who own and use a ClearBlue Fertility monitor and who will be asked to simultaneously use the Mira monitor for the sake of comparing the two devices.

• Female participants invited to participate will need to meet the following criteria:

• Age 18 to 42 years

• Menstrual cycle ranging between 21-42 days

• At least 3 cycles after cessation of breastfeeding

• Not currently on medications that affect ovulation and 3 months prior

• Not currently pregnant or breastfeeding

• No known fertility problems

• Not planning on achieving pregnancy during the 3 menstrual cycles of the study ;

Related Conditions & MeSH terms

• Fertility Disorders

• NCT number: NCT03908697
• Study type: Interventional
• Source: Quanovate Tech Inc.
• Status: Completed
• Phase: N/A
• Start date: May 29, 2020
• Completion date: April 22, 2021